论文部分内容阅读
目的 :选择具有协同免疫调节作用的生物制剂进行联合治疗是提高肿瘤生物治疗 ,减少抗癌药物的副作用。方法 :40只Ｃ57ＢＬ/6小鼠右侧腋下皮下接种Ｌｅｗｉｓ肺癌瘤株 (ＬＬＣ) 1 5× 1 0 6实验分 4组 ,每组 1 0只小鼠 ,Ⅰ组为对照组 ,注射生理盐水 ;Ⅱ组注射康赛宁 ;Ⅲ组为注
Objective : To select biological agents with synergistic immunomodulatory effects for combination therapy is to improve the biological treatment of tumors and reduce the side effects of anticancer drugs. METHODS: Forty C57BL/6 mice were inoculated subcutaneously with Lewis lung cancer (LLC) 15×106 into the right subdiaphragm. The experiment was divided into 4 groups. Each group contained 10 mice. Group I was the control group. Group II was injected Conesonin; Group III was injected